US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 8.610
  • -0.210-2.38%
Trading Jan 24 11:13 ET
587.64MMarket Cap-4.33P/E (TTM)

About EyePoint Pharmaceuticals Company

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Company Profile

SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees121
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Websitehttp://www.eyepointpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay S. Duker, M.D.
  • Director, President and Chief Executive Officer
  • 2.92M
  • George O. Elston
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 1.78M
  • Dr. Ramiro Ribeiro, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Goran A. Ando, M.D.
  • Chairman of the Board
  • 214.78K
  • Nancy S. Lurker
  • Executive Vice Chairman of the Board
  • 3.74M
  • Dr. John B. Landis, PhD
  • Director
  • 161.67K
  • Fred Hassan
  • Director
  • --
  • Dr. Reginald Sanders, M.D.
  • Director
  • --
  • Stuart M. Duty
  • Independent Director
  • 381.10K
  • Wendy F. DiCicco
  • Independent Director
  • 171.67K
  • Karen Zaderej
  • Independent Director
  • 149.17K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Big Tech’s earnings season kicks off: How will market react?
🎙️ Discussion: 1. Can Big Tech earnings lead all sectors higher again? 2. How will the tech giants be affected by the "Trump Factor"? Show More
What You Need to Know Ahead of Big Tech Earnings